AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Hongguan Biopharmaceutical Co., Ltd., established on 2013-04-02, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Technology Import and Export;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Industrial Design Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions. The company was founded on January 7, 1958 and is headquartered in Seoul, South Korea.

Shanghai Hongguan Pharmaceutical Technology Co., Ltd., established on 2018-08-30, The scope of business includes engaging in biotechnology(genetically modified organism,Except human stem cell genetic diagnosis),Technology development in the field of medical science and technology,technical consulting,technology transfer,translate,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of,Engaged in the import and export of goods and technology,Technical extension services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Henan Provincial Peoples Hospital is a private company headquartered in Zhengzhou, China, that operates as an hospital.

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. Its products include pharmaceutical preparations, raw materials, pharmaceutical excipients, plant extracts, anti-infective drugs, anti-allergic drugs, digestive system drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, gynecological drugs, tonics, and topical plasters. The company was founded on January 19, 2001 and is headquartered in Changsha, China.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Yueyang Xinhuada Pharmaceutical Co., Ltd., established on 2009-06-16, The business scope includes small volume injections,Oral liquid(Contains Chinese herbal extracts),Chinese medicine pretreatment,oral solution,Solution(external use),ointment,cream,suppositories,Granules(dry suspension),tablet,Capsules,API(Aripiprazole,Cinacalcet hydrochloride,Levoamlodipine Besylate,Bisoprolol Fumarate,selenium yeast,Propofol,Teprenone,palmitate,Vandetanil,Povidone iodine,Nicorandil)production,Drug research and development,Biological control technology development services,medical consultation(Does not contain medical diagnoses),Peracetic acid solution,Manufacture and sales of alcohol sanitizers(Hazardous chemicals according to<Hazardous Chemical Business License>Approved method and scope of operation),Manufacture and sales of health food.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Draco provides concrete additives, concrete curing, mold oils, plastering, anchoring, installation, decorative concrete-asphalt, floor coverings, thermal insulation, water isolation, primer, adhesives, ceramic adhesives, protective coatings, and so on.

Lite Pharm Tech Co., Ltd. develops biopharmaceutical products. Its products include Zinctrace, Selinew, and Cindella injection, photosensitizer, Multiblue-5, and cancer treatment and diagnosis system known as photodynamic therapy and photodynamic diagnosis. The company was founded on January 25, 2005 and is headquartered in Seoul, South Korea.

HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.

Aisher (Shenzhen) Drug Research and Development Co., Ltd., established on 2016-07-26, Business scope includes general business items:Technical process development services for pharmaceutical products;chemical compound(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)research and development,detection,Sales;Domestic Trade;technical consulting(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).,The licensing program is:R&D of pharmaceutical intermediates,production and sales;Synthesis of drug-related compounds.

Boehringer Ingelheim KG, part of C.H. Boehringer Sohn AG & Co. KG, is a company headquartered in Biberach, Germany. The firm wholesales pharmaceutical products. It was founded in 1981.

Shanghai Xinsheng Pharmaceutical Technology Co., Ltd., established on 2008-01-09, Business scope includes biological,Technology development in the field of medical expertise,technical consulting,Technical Services,technology transfer(GMOs,Human Stem Cell Genetic Diagnosis),translate,chemical reagent(except medical,Diagnostic reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),medical instruments(Limited to one category)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.